140 related articles for article (PubMed ID: 17576820)
1. 6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis.
Soares-Schanoski A; Gómez-Piña V; del Fresno C; Rodríguez-Rojas A; García F; Glaría A; Sánchez M; Vallejo-Cremades MT; Baos R; Fuentes-Prior P; Arnalich F; López-Collazo E
J Leukoc Biol; 2007 Sep; 82(3):700-9. PubMed ID: 17576820
[TBL] [Abstract][Full Text] [Related]
2. IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation.
Li H; Cuartas E; Cui W; Choi Y; Crawford TD; Ke HZ; Kobayashi KS; Flavell RA; Vignery A
J Exp Med; 2005 Apr; 201(7):1169-77. PubMed ID: 15809356
[TBL] [Abstract][Full Text] [Related]
3. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulphate inhibits osteoclast differentiation and function.
Mozar A; Louvet L; Godin C; Mentaverri R; Brazier M; Kamel S; Massy ZA
Nephrol Dial Transplant; 2012 Jun; 27(6):2176-81. PubMed ID: 22140126
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages.
De Nardo D; Nguyen T; Hamilton JA; Scholz GM
Cell Signal; 2009 Feb; 21(2):246-52. PubMed ID: 18992325
[TBL] [Abstract][Full Text] [Related]
6. IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.
Gupta N; Barhanpurkar AP; Tomar GB; Srivastava RK; Kour S; Pote ST; Mishra GC; Wani MR
J Immunol; 2010 Aug; 185(4):2261-72. PubMed ID: 20644169
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
8. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
9. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
10. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
12. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
[TBL] [Abstract][Full Text] [Related]
13. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
Merle B; Itzstein C; Delmas PD; Chenu C
J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
[TBL] [Abstract][Full Text] [Related]
14. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.
Tanaka Y; Maruo A; Fujii K; Nomi M; Nakamura T; Eto S; Minami Y
J Bone Miner Res; 2000 Oct; 15(10):1912-23. PubMed ID: 11028443
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression.
Zacharioudaki V; Androulidaki A; Arranz A; Vrentzos G; Margioris AN; Tsatsanis C
J Immunol; 2009 May; 182(10):6444-51. PubMed ID: 19414798
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
18. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
Li CH; Wang JH; Redmond HP
J Leukoc Biol; 2006 Apr; 79(4):867-75. PubMed ID: 16461741
[TBL] [Abstract][Full Text] [Related]
19. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts.
Saintier D; Burde MA; Rey JM; Maudelonde T; de Vernejoul MC; Cohen-Solal ME
J Cell Physiol; 2004 Feb; 198(2):269-76. PubMed ID: 14603529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
